AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-86
Results: 51-75/86
ACETYLSALICYLIC-ACID MAY PROTECT THE PATIENT BY INCREASING FIBRIN GELPOROSITY - DANGER OF WITHDRAWING TREATMENT
Authors: FATAH K BEVING H ALBAGE A IVER T BLOMBACK M
Citation: K. Fatah et al., ACETYLSALICYLIC-ACID MAY PROTECT THE PATIENT BY INCREASING FIBRIN GELPOROSITY - DANGER OF WITHDRAWING TREATMENT, Thrombosis and haemostasis, 73(6), 1995, pp. 1228-1228
A PRESENT LEVEL OF HEMOSTATIC VARIABLE MAY PREDICT WHAT HAPPENS UNDERHORMONAL INFLUENCE
Authors: BLOMBACK M ANDERSSON O BREMME K WRAMSBY H
Citation: M. Blomback et al., A PRESENT LEVEL OF HEMOSTATIC VARIABLE MAY PREDICT WHAT HAPPENS UNDERHORMONAL INFLUENCE, Thrombosis and haemostasis, 73(6), 1995, pp. 1233-1233
ANTITHROMBIN(III) SUPPLEMENTATION TO PATIENTS UNDERGOING PTCA FOR UNSTABLE ANGINA-PECTORIS
Authors: GRIP L BLOMBACK M EGBERG N OLSSON A SVANE B VELANDER M
Citation: L. Grip et al., ANTITHROMBIN(III) SUPPLEMENTATION TO PATIENTS UNDERGOING PTCA FOR UNSTABLE ANGINA-PECTORIS, Thrombosis and haemostasis, 73(6), 1995, pp. 1250-1250
PLASMINOGEN-ACTIVATOR INHIBITORS (PAI-1 AND PAI-2) IN PREECLAMPSIA - DECREASES IN PAI-2 SUGGESTING PLACENTAL OR FETAL COMPLICATIONS AND FETUS ASSUMED TO BE ONE OF REGULATORS OF PAI-2 SYNTHESIS
Authors: HE S BREMME K ALMQVIST I BLOMBACK M
Citation: S. He et al., PLASMINOGEN-ACTIVATOR INHIBITORS (PAI-1 AND PAI-2) IN PREECLAMPSIA - DECREASES IN PAI-2 SUGGESTING PLACENTAL OR FETAL COMPLICATIONS AND FETUS ASSUMED TO BE ONE OF REGULATORS OF PAI-2 SYNTHESIS, Thrombosis and haemostasis, 73(6), 1995, pp. 1302-1302
HETEROGENEITY OF APC RESISTANCE PHENOMENON AND THE MUTATION IN FACTOR-V GENE CAUSING ARG506-GLN SUBSTITUTION
Authors: BOKAREWA MI BLOMBACK M
Citation: Mi. Bokarewa et M. Blomback, HETEROGENEITY OF APC RESISTANCE PHENOMENON AND THE MUTATION IN FACTOR-V GENE CAUSING ARG506-GLN SUBSTITUTION, Thrombosis and haemostasis, 73(6), 1995, pp. 1366-1366
THROMBOTIC RISK-FACTORS AND ORAL CONTRACEPTION (OC)
Authors: BREMME K BLOMBACK M BOKAREWA M FALCK G STENLINDER M
Citation: K. Bremme et al., THROMBOTIC RISK-FACTORS AND ORAL CONTRACEPTION (OC), Thrombosis and haemostasis, 73(6), 1995, pp. 1376-1376
CHANGES IN THE RESPONSE TO ACTIVATED PROTEIN-C DURING PREGNANCY
Authors: BOKAREWA MI BLOMBACK M BREMME K
Citation: Mi. Bokarewa et al., CHANGES IN THE RESPONSE TO ACTIVATED PROTEIN-C DURING PREGNANCY, Thrombosis and haemostasis, 73(6), 1995, pp. 1377-1377
FIBRINOGEN GENOTYPE, PLASMA-FIBRINOGEN LEVEL AND FIBRIN GEL PROPERTIES IN YOUNG MYOCARDIAL-INFARCTION PATIENTS AND HEALTHY CONTROLS FROM SWEDEN
Authors: CURRAN J HAMSTEN A FATAH K BLOMBACK M HUMPHRIES S GREEN F
Citation: J. Curran et al., FIBRINOGEN GENOTYPE, PLASMA-FIBRINOGEN LEVEL AND FIBRIN GEL PROPERTIES IN YOUNG MYOCARDIAL-INFARCTION PATIENTS AND HEALTHY CONTROLS FROM SWEDEN, Thrombosis and haemostasis, 73(6), 1995, pp. 1379-1379
RELATIONSHIPS OF INSULIN AND INTACT AND SPLIT PROINSULIN TO HEMOSTATIC FUNCTION IN YOUNG MEN WITH AND WITHOUT CORONARY-ARTERY DISEASE
Authors: BAVENHOLM P PROUDLER A SILVEIRA A CROOK D BLOMBACK M DEFAIRE U HAMSTEN A
Citation: P. Bavenholm et al., RELATIONSHIPS OF INSULIN AND INTACT AND SPLIT PROINSULIN TO HEMOSTATIC FUNCTION IN YOUNG MEN WITH AND WITHOUT CORONARY-ARTERY DISEASE, Thrombosis and haemostasis, 73(4), 1995, pp. 568-575
STUDIES ON PHOSPHOLIPID ANTIBODIES, APC-RESISTANCE AND ASSOCIATED MUTATION IN THE COAGULATION-FACTOR-V GENE
Authors: BOKAREWA MI BREMME K FALK G STENLINDER M EGBERG N BLOMBACK M
Citation: Mi. Bokarewa et al., STUDIES ON PHOSPHOLIPID ANTIBODIES, APC-RESISTANCE AND ASSOCIATED MUTATION IN THE COAGULATION-FACTOR-V GENE, Thrombosis research, 78(3), 1995, pp. 193-200
THROMBOTIC RISK-FACTORS AND ORAL CONTRACEPTION
Authors: BOKAREWA MI FALK G STENLINDER M EGBERG N BLOMBACK M BREMME K
Citation: Mi. Bokarewa et al., THROMBOTIC RISK-FACTORS AND ORAL CONTRACEPTION, The Journal of laboratory and clinical medicine, 126(3), 1995, pp. 294-298
ABNORMAL FIBRIN-GEL FORMATION, AND A DECREASED SKIN CAPILLARY CIRCULATION IN THE FEET OF DIABETIC-PATIENTS
Authors: JORNESKOG G FAGRELL B FATAH K HESSEL B JOHNSSON H BRISMAR K BLOMBACK M
Citation: G. Jorneskog et al., ABNORMAL FIBRIN-GEL FORMATION, AND A DECREASED SKIN CAPILLARY CIRCULATION IN THE FEET OF DIABETIC-PATIENTS, Diabetes, 44, 1995, pp. 218-218
ACTIVATION OF COAGULATION-FACTOR-VII DURING ALIMENTARY LIPEMIA
Authors: SILVEIRA A KARPE F BLOMBACK M STEINER G WALLDIUS G HAMSTEN A
Citation: A. Silveira et al., ACTIVATION OF COAGULATION-FACTOR-VII DURING ALIMENTARY LIPEMIA, Arteriosclerosis and thrombosis, 14(1), 1994, pp. 60-69
DO LOWERED FACTOR-VII LEVELS AT EXTREMELY HIGH ENDOGENOUS ESTRADIOL LEVELS PROTECT AGAINST THROMBIN FORMATION
Authors: BREMME K WRAMSBY H ANDERSSON O WALLIN M BLOMBACK M
Citation: K. Bremme et al., DO LOWERED FACTOR-VII LEVELS AT EXTREMELY HIGH ENDOGENOUS ESTRADIOL LEVELS PROTECT AGAINST THROMBIN FORMATION, Blood coagulation & fibrinolysis, 5(2), 1994, pp. 205-210
A NEW VARIANT OF INTERACTION BETWEEN PHOSPHOLIPID ANTIBODIES AND THE PROTEIN-C SYSTEM
Authors: BOKAREWA MI BLOMBACK M EGBERG N ROSEN S
Citation: Mi. Bokarewa et al., A NEW VARIANT OF INTERACTION BETWEEN PHOSPHOLIPID ANTIBODIES AND THE PROTEIN-C SYSTEM, Blood coagulation & fibrinolysis, 5(1), 1994, pp. 37-41
CHARACTERIZATION OF THE VON-WILLEBRAND-FACTOR GENE (VWF) IN VON-WILLEBRAND DISEASE TYPE-III PATIENTS FROM 24 FAMILIES OF SWEDISH AND FINNISH ORIGIN
Authors: ZHANG ZP BLOMBACK M EGBERG N FALK G ANVRET M
Citation: Zp. Zhang et al., CHARACTERIZATION OF THE VON-WILLEBRAND-FACTOR GENE (VWF) IN VON-WILLEBRAND DISEASE TYPE-III PATIENTS FROM 24 FAMILIES OF SWEDISH AND FINNISH ORIGIN, Genomics, 21(1), 1994, pp. 188-193
SOLUBLE FIBRIN - A PREDICTOR FOR THE DEVELOPMENT AND OUTCOME OF MULTIPLE ORGAN FAILURE
Authors: BREDBACKA S BLOMBACK M WIMAN B
Citation: S. Bredbacka et al., SOLUBLE FIBRIN - A PREDICTOR FOR THE DEVELOPMENT AND OUTCOME OF MULTIPLE ORGAN FAILURE, American journal of hematology, 46(4), 1994, pp. 289-294
ELEVATED LEVELS OF FACTOR-VII ACTIVITY IN THE POSTPRANDIAL STATE - EFFECT OF THE FACTOR-VII ARG-GLN POLYMORPHISM
Authors: SILVEIRA A GREEN F KARPE F BLOMBACK M HUMPHRIES S HAMSTEN A
Citation: A. Silveira et al., ELEVATED LEVELS OF FACTOR-VII ACTIVITY IN THE POSTPRANDIAL STATE - EFFECT OF THE FACTOR-VII ARG-GLN POLYMORPHISM, Thrombosis and haemostasis, 72(5), 1994, pp. 734-739
HEMOSTATIC FACTORS AND INHIBITORS AND CORONARY-ARTERY BYPASS-GRAFTING- PREOPERATIVE ALTERATIONS AND RELATIONS TO GRAFT OCCLUSION
Authors: MOOR E HAMSTEN A BLOMBACK M HERZFELD I WIMAN B RYDEN L
Citation: E. Moor et al., HEMOSTATIC FACTORS AND INHIBITORS AND CORONARY-ARTERY BYPASS-GRAFTING- PREOPERATIVE ALTERATIONS AND RELATIONS TO GRAFT OCCLUSION, Thrombosis and haemostasis, 72(3), 1994, pp. 335-342
RELATIONSHIP OF TISSUE FACTOR PATHWAY INHIBITOR ACTIVITY TO PLASMA-LIPOPROTEINS AND MYOCARDIAL-INFARCTION AT A YOUNG AGE
Authors: MOOR E HAMSTEN A KARPE F BAVENHOLM P BLOMBACK M SILVEIRA A
Citation: E. Moor et al., RELATIONSHIP OF TISSUE FACTOR PATHWAY INHIBITOR ACTIVITY TO PLASMA-LIPOPROTEINS AND MYOCARDIAL-INFARCTION AT A YOUNG AGE, Thrombosis and haemostasis, 71(6), 1994, pp. 707-712
NOMENCLATURE OF QUANTITIES AND UNITS IN THROMBOSIS AND HEMOSTASIS (RECOMMENDATION 1993) - A COLLABORATIVE PROJECT OF THE SCIENTIFIC AND STANDARDIZATION COMMITTEE OF THE INTERNATIONAL-SOCIETY-ON-THROMBOSIS-AND-HEMOSTASIS (ISTH SSC) AND THE COMMISSION COMMITTEE ON QUANTITIES AND UNITS (IN CLINICAL-CHEMISTRY) OF THE INTERNATIONAL-UNION-OF-PURE-AND-APPLIED-CHEMISTRY INTERNATIONAL-FEDERATION-OF-CLINICAL-CHEMISTRY
Authors: BLOMBACK M ABILDGAARD U VANDENBESSELAAR AMHP CLEMENTSON KJ DAHLBACK B EXNER T FRANCIS CW GAFFNEY P GRALNICK H HOYER LW JOHNSON GJ KASPER C LANE D LIJNEN HR LUSHER JM MANNUCCI PM POLLER L RAPAPORT SI SAITO H STOCKER K THOMAS D BARROWCLIFFE TW HEMKER C THORSEN S ARONSON D MANN KG MEYER D ROBERTS HR DYBKAER R JORGENSEN K OLESEN H
Citation: M. Blomback et al., NOMENCLATURE OF QUANTITIES AND UNITS IN THROMBOSIS AND HEMOSTASIS (RECOMMENDATION 1993) - A COLLABORATIVE PROJECT OF THE SCIENTIFIC AND STANDARDIZATION COMMITTEE OF THE INTERNATIONAL-SOCIETY-ON-THROMBOSIS-AND-HEMOSTASIS (ISTH SSC) AND THE COMMISSION COMMITTEE ON QUANTITIES AND UNITS (IN CLINICAL-CHEMISTRY) OF THE INTERNATIONAL-UNION-OF-PURE-AND-APPLIED-CHEMISTRY INTERNATIONAL-FEDERATION-OF-CLINICAL-CHEMISTRY, Thrombosis and haemostasis, 71(3), 1994, pp. 375-394
HETEROGENEITY OF THE APC-RESISTANCE PHENOMENON
Authors: BOKAREWA M BLOMBACK M
Citation: M. Bokarewa et M. Blomback, HETEROGENEITY OF THE APC-RESISTANCE PHENOMENON, Thrombosis research, 75(4), 1994, pp. 395-400
RELEASE OF VON-WILLEBRAND-FACTOR BY CARDIOPULMONARY BYPASS, BUT NOT BY CARDIOPLEGIA IN OPEN-HEART-SURGERY
Authors: VALEN G BLOMBACK M SELLEI P LINDBLOM D VAAGE J
Citation: G. Valen et al., RELEASE OF VON-WILLEBRAND-FACTOR BY CARDIOPULMONARY BYPASS, BUT NOT BY CARDIOPLEGIA IN OPEN-HEART-SURGERY, Thrombosis research, 73(1), 1994, pp. 21-29
PLASMA-LEVELS OF VON-WILLEBRAND-FACTOR AND FIBRONECTIN AS MARKERS OF PERSISTING ENDOTHELIAL DAMAGE IN PREECLAMPSIA
Authors: DENG LP BREMME K HANSSON LO BLOMBACK M
Citation: Lp. Deng et al., PLASMA-LEVELS OF VON-WILLEBRAND-FACTOR AND FIBRONECTIN AS MARKERS OF PERSISTING ENDOTHELIAL DAMAGE IN PREECLAMPSIA, Obstetrics and gynecology, 84(6), 1994, pp. 941-945
THE ROLE OF BETA-FIBRINOGEN GENOTYPE IN DETERMINING PLASMA-FIBRINOGENLEVELS IN YOUNG SURVIVORS OF MYOCARDIAL-INFARCTION AND HEALTHY CONTROLS FROM SWEDEN
Authors: GREEN F HAMSTEN A BLOMBACK M HUMPHRIES S
Citation: F. Green et al., THE ROLE OF BETA-FIBRINOGEN GENOTYPE IN DETERMINING PLASMA-FIBRINOGENLEVELS IN YOUNG SURVIVORS OF MYOCARDIAL-INFARCTION AND HEALTHY CONTROLS FROM SWEDEN, Thrombosis and haemostasis, 70(6), 1993, pp. 915-920
Risultati: 1-25 | 26-50 | 51-75 | 76-86